USE OF A HER2 ANTIBODY AND A CHEMOTHERAPEUTIC AGENT IN THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR TREATING PLATINUM-RESISTANT CANCER

• 收藏
• 分享

专利权人:

GENENTECH; INC.

发明人:

申请号：

IL17940106

公开号：

IL179401A

申请日:

2006.11.20

申请国别(地区):

IL

年份:

2012

代理人:

摘要：

The present invention concerns a method for treating platinum-resistant, ovarian cancer, primary peritoneal carcinoma or fallopian tube carcinoma with the combination of a HER2 antibody that effectively inhibits HER dimerization as well as gemcitabine.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/